Validation of the SARC-F for Assessing Sarcopenia in Patients on Peritoneal Dialysis

J Ren Nutr. 2022 May;32(3):341-346. doi: 10.1053/j.jrn.2021.03.012. Epub 2021 May 28.

Abstract

Objective: Proper screening or diagnosis of sarcopenia (SP) is important to obtain favorable outcomes in patients on peritoneal dialysis (PD). Previous studies have shown that the SARC-F is associated with various parameters of SP in elderly populations. In this study, we aimed to validate the SARC-F questionnaire for predicting SP in patients on PD.

Methods: This cross-sectional study was conducted at a tertiary medical center. We identified all patients prevalent on PD patients (n = 127). A version of the original SARC-F was used to assess the questionnaire. Patients with a total score of ≥4 points were defined as the high group and those with <4 points were defined as the normal group. The hand grip strength and appendicular skeletal muscle mass index were measured in all patients. SP was defined as previously reported.

Results: Of the 127 total patients, 29 (22.8%, high group) had an SARC-F score of ≥4. The sensitivity and specificity of the SARC-F for predicting SP were 70.0% and 81.2%, respectively. The negative predictive and positive predictive values were 96.9% and 24.1%, respectively. The area under curve of the SARC-F score for SP was 0.791 (0.709-0.858, P < .001). The hand grip strength of the normal and high groups was 26.4 ± 8.5 and 19.5 ± 6.8 kg, respectively (P < .001). The appendicular skeletal muscle mass index in the normal and high groups was 7.6 ± 1.3 and 7.2 ± 1.8 kg/m2, respectively (P = .152). An increase in the SARC-F score as a continuous variable or classification into the high group as a categorical variable was associated with a higher odds ratio for SP in univariate and multivariate analyses.

Conclusion: The SARC-F has a high negative predictive value and a high specificity for predicting SP in patients on PD.

MeSH terms

  • Aged
  • Cross-Sectional Studies
  • Geriatric Assessment
  • Hand Strength
  • Humans
  • Peritoneal Dialysis* / adverse effects
  • Sarcopenia* / diagnosis
  • Sarcopenia* / epidemiology
  • Surveys and Questionnaires